CTI BioPharma Corp.

CTIC · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$93-$98-$52-$40
Dep. & Amort.$2$1$1$1
Deferred Tax$0$0$4-$1
Stock-Based Comp.$10$5$4$5
Change in WC-$8$8-$2$8
Other Non-Cash$8-$0$4$0
Operating Cash Flow-$81-$85-$42-$28
Investing Activities
PP&E Inv.-$25$0-$0$0
Net Acquisitions$25$0$0$0
Inv. Purchases-$89$0-$12-$11
Inv. Sales/Matur.$40$12$3$39
Other Inv. Act.-$25$0$0$0
Investing Cash Flow-$74$12-$10$28
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$57$59$66$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$120$98$61-$6
Financing Cash Flow$120$98$61-$6
Forex Effect$0$0$0$0
Net Chg. in Cash-$35$25$9-$5
Supplemental Information
Beg. Cash$65$40$31$36
End Cash$30$65$40$31
Free Cash Flow-$106-$85-$42-$28